Cellular and Molecular Pharmacology

CMP Seminars 2011-2012

September 7, 2011
11 AM
Fernando Gomez-Pinilla, PhD
University of California at Los Angeles
Los Angeles, CA
Natural Mood Foods: The Actions of Diet and Exercise Against Cognitive and Neurological Disorders
September 21, 2011
11 AM
Paul Carvey , PhD
Rush University
Chicago, IL
Compensatory Angiogenesis in Parkinison’s Disease
October 26, 2011
11 AM
Wen-Jun Gao , PhD
Drexel University College of Medicine
Philadelphia, PA
Properties of NMDA Receptors in the Prefrontal Cortex and Dopamine Regulation
November 2, 2011
11 AM
Marilyn Carroll , PhD
University of Minnesota
Minneapolis, MN
Individual Differences (Sex, Avidity for Sweets, Exercise, and Novelty) and How They Predict Rewarding and Aversive Effects of Drugs of Abuse
November 30, 2011
11 AM
Judith R. Walters, PhD
Bethesda, MD
Basal Ganglia Oscillations in Parkinson’s Disease: Is Too Much Rhythm a Bad Thing?
December 7, 2011
11 AM
Paul Gasser, PhD
Marquette University
Milwaukee, WI
Contribution of a Glucocorticoid-sensitive Monoamine Transporter to Stress-Induced Increases in Cocaine Relapse Vulnerability
January 18, 2012
11 AM
Peter Penzes, PhD
Northwestern University
Evanston, IL
Molecular Mechanisms of Synaptic Structural Plasticity and Pathology
January 25, 2012
11 AM
Daniel Lodge, PhD
University of Texas Health Science Center
San Antonio, TX
The Hippocampus as a Therapeutic Target for Schizophrenia
April 4, 2012
11 AM
Scott Zahm, PhD
Saint Louis University School of Medicine
Saint Louis, MO
Pardon Me, you were Expecting What? Circuitry of the Rostromedial Tegmental Nucleus
April 25, 2012
11 AM
Anthony Grace, PhD
University of Pittsburgh
Pittsburgh, PA
Dopamine System Dysregulation by the Hippocampus and the Pathophysiology of Schizophrenia
May 16, 2012
11 AM
Matthew Hill, PhD
University of Calgary
Calgary, AB, Canada
Stress, Endocannabinoids and the Amygdala